Scandinavian Medical Solutions (SMSMED.CO) Stock Analysis & AI Equity Report

Medical - Devices DKK Explore free reports

Scandinavian Medical Solutions (SMSMED.CO) overview

Scandinavian Medical Solutions (SMSMED.CO) stock analysis and AI equity research. For the latest completed financial year, 2024, Scandinavian Medical Solutions reported revenue of DKK 227m and operating profit of DKK 13.8m; the year-end share price was N/A and market capitalisation was N/A. Scandinavian Medical Solutions is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Scandinavian Medical Solutions's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueDKK 82.5mFY 2024
Share priceN/AFY 2024 year end
RevenueDKK 227mFY 2024
Operating profitDKK 13.8mFY 2024
Net earningsDKK 7.8mFY 2024
Market capitalisationN/AFY 2024 year end

Figures updated on 2025-06-18. Data will be refreshed during report generation.

About Scandinavian Medical Solutions

Scandinavian Medical Solutions A/S buys, sells, and rents pre-owned diagnostic imaging equipment, including MRI, CT, PET/CT, X-ray, and ultrasound systems. It also supplies spare parts and manages related deinstallation, logistics, and aftersales support for hospitals, clinics, and distributors, with operations centered in Denmark and serving international customers.

Generate the Scandinavian Medical Solutions report

Scandinavian Medical Solutions is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Scandinavian Medical Solutions and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.